ifosfamide has been researched along with Chronic Kidney Failure in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen pediatric osteosarcoma patients, previously treated with conventional chemotherapy (including ifosfamide (IFX), 9 g/m(2)) were retreated with high-dose ifosfamide (HD-IFX, 14 g/m(2) per course), following relapse or development of a new bone tumor." | 7.73 | High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity. ( Berberoğlu, S; Berrak, SG; Ilhan, IE; Jaffe, N; Pearson, M, 2005) |
| "A 67-year-old male patient developed progressive renal failure following successful treatment of a soft tissue sarcoma that comprised surgical resection after neoadjuvant radiochemotherapy with the application of doxorubicin (cumulative dose 180 mg/m²) and ifosfamide (cumulative dose 33 g/m²)." | 3.80 | [End-stage renal disease after sarcoma therapy - case 3/2014]. ( Amann, K; Artunc, F; Bakos, G; Baumann, D; Bunz, H; Ciarimboli, G; Kluba, T; Kopp, HG; Müller, M; Schlatter, E; Steinke, I; Weyrich, P, 2014) |
| "Sixteen pediatric osteosarcoma patients, previously treated with conventional chemotherapy (including ifosfamide (IFX), 9 g/m(2)) were retreated with high-dose ifosfamide (HD-IFX, 14 g/m(2) per course), following relapse or development of a new bone tumor." | 3.73 | High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity. ( Berberoğlu, S; Berrak, SG; Ilhan, IE; Jaffe, N; Pearson, M, 2005) |
| "Ifosfamide is a nitrogen mustard alkylating agent used as both a first-line and a salvage chemotherapeutic agent in the treatment of testicular germ cell tumors, various sarcomas, carcinomas, and some lymphomas." | 1.40 | Chronic Ifosfamide toxicity: kidney pathology and pathophysiology. ( Akilesh, S; Duffield, JS; Juaire, N; Smith, KD, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akilesh, S | 1 |
| Juaire, N | 1 |
| Duffield, JS | 1 |
| Smith, KD | 1 |
| Baumann, D | 1 |
| Amann, K | 1 |
| Schlatter, E | 1 |
| Ciarimboli, G | 1 |
| Kopp, HG | 1 |
| Müller, M | 1 |
| Kluba, T | 1 |
| Bakos, G | 1 |
| Steinke, I | 1 |
| Bunz, H | 1 |
| Weyrich, P | 1 |
| Artunc, F | 1 |
| Berrak, SG | 1 |
| Pearson, M | 1 |
| Berberoğlu, S | 1 |
| Ilhan, IE | 1 |
| Jaffe, N | 1 |
| Keaney, CM | 1 |
| Springate, JE | 1 |
| Krämer, A | 2 |
| Goldschmidt, H | 1 |
| Hahn, U | 1 |
| Andrassy, K | 2 |
| Berns, JS | 1 |
| Haghighat, A | 1 |
| Staddon, A | 1 |
| Cohen, RM | 1 |
| Schmidt, R | 1 |
| Fisher, S | 1 |
| Rudnick, MR | 1 |
| Tomaszewski, JE | 1 |
| Prasad, VK | 1 |
| Lewis, IJ | 1 |
| Aparicio, SR | 1 |
| Heney, D | 1 |
| Hale, JP | 1 |
| Bailey, CC | 1 |
| Kinsey, SE | 1 |
| Martinez, F | 1 |
| Deray, G | 1 |
| Cacoub, P | 1 |
| Beaufils, H | 1 |
| Jacobs, C | 1 |
| Friedlaender, MM | 1 |
| Haviv, YS | 1 |
| Rosenmann, E | 1 |
| Peylan-Ramu, N | 1 |
| Girón, FF | 1 |
| de la Vega, RL | 1 |
| Eguinoa, JE | 1 |
| Perez, MJ | 1 |
| Sanchez, MB | 1 |
| Rodriguez, CS | 1 |
| Rico, JM | 1 |
| Ho, AD | 1 |
1 review available for ifosfamide and Chronic Kidney Failure
| Article | Year |
|---|---|
Cancer and the kidney.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma, Renal Cell; Comorbi | 2005 |
10 other studies available for ifosfamide and Chronic Kidney Failure
| Article | Year |
|---|---|
Chronic Ifosfamide toxicity: kidney pathology and pathophysiology.
Topics: Antineoplastic Agents, Alkylating; Biopsy; Dose-Response Relationship, Drug; Drug Administration Sch | 2014 |
[End-stage renal disease after sarcoma therapy - case 3/2014].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential | 2014 |
High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Female; Hu | 2005 |
Progressive renal failure in two breast cancer patients after high-dose ifosfamide.
Topics: Adult; Breast Neoplasms; Female; Humans; Ifosfamide; Kidney Failure, Chronic; Middle Aged | 1994 |
Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients.
Topics: Antineoplastic Agents, Alkylating; Humans; Ifosfamide; Kidney; Kidney Failure, Chronic; Male; Middle | 1995 |
Progressive glomerular toxicity of ifosfamide in children.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Creatinine; Female; Glomerul | 1996 |
Ifosfamide nephrotoxicity: deleterious effect of previous cisplatin administration.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Female; Humans; Ifosfamide; Kidney Failure, Chronic; | 1996 |
End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Fibrosis; Humans; Ifosfamide; Kidney; Kidney Failure, Chro | 1998 |
End-stage chronic renal failure secondary to cisplatin and ifosfamide combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Kidney; Kidney | 1999 |
Renal failure after bone marrow transplantation.
Topics: Acute Kidney Injury; Bone Marrow Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Kidn | 2001 |